Dr Judson Brewer on the 10% Happier Podcast with Dan Harris - Using Mindfulness to Beat Addiction -
https://itunes.apple.com/us/podcast/61-dr-judson-brewer-using-mindfulness-to-beat-addiction/id1087147821?i=1000381235048&mt=2
The Warrior Podcast: The Neuroscience of Mindfulness and Experiencing Flow with Judson Brewer
On this episode of the podcast, host Tony Balbin and Dr. Brewer discuss mindfulness, the flow state, the brain, the Default Mode Network and more…
Craving Freedom - Charlotte Lieberman reviews The Craving Mind by Judson Brewer, MD, PhD, on the Garrison Institute blog.
Off the hook - how to have a better relationship with your smart phone - Judson Brewer on the ‘All in the Mind’ podcast.
From the website: “Life seems to be moving at an ever increasing pace, and your digital device might be in the driver’s seat. It’s often the first thing you check in the morning and the last thing before sleep. Your mind may crave mobile phone use, in the same way that it can crave cigarettes or food. The reward is a spritz of dopamine in your brain. We learn how to renegotiate your relationship with your smart phone.”
National Geographic Magazine, September 2017: How Science Is Unlocking the Secrets of Addiction
In this in-depth article, Dr. Brewer is quoted on treatment of addiction through a combination of modern science and ancient contemplative practice.
mindful.org: 10 Mindfulness Researchers You Should Know
"Key insights from leading researchers spotlight what we know, what we don’t know, and what the future holds for the science of mindfulness."
tricycle.org: The Division of Mindfulness at the University of Massachusetts Medical School
Says Dr. Brewer: “The creation of a stand-alone Division of Mindfulness embedded within a Department of Medicine highlights how far the field has progressed and matured, and will create the infrastructure and support for researchers dedicated to furthering our neuroscientific knowledge of how the mind works, and for what medical conditions mindfulness is efficacious.”
From the Washington Post:
“Our brains are not set up to think into the future very much,” said Judson Brewer, director of research at the Center for Mindfulness at the University of Massachusetts Medical School. “So it’s really challenging until we really pay attention to the immediate behavior to be able to step out of it.”
Judson Brewer one of 5 Winners of the Ohio Opioid Technology Challenge
Dr. Judson Brewer was one of five winners in a global technology challenge for ideas to help solve the opioid crisis, according to an announcement made Tuesday. (Worcester Telegram)
Craving - Judson Brewer on the All in the Mind podcast
Our craving mind works as a rewards-based system, but it can be understood better. To start the new year, Dr. Brewer speaks with host Lynne Malcolm about how we could mend our ways.
Mindful Magazine online: UMass Medical School Creates First Division of Mindfulness
“We are now understanding the seamless interconnectedness of brain, mind, body, experience, and well-being. This show of support for furthering the inquiry has the potential to inform the development of increasingly effective targeted clinical programs under the umbrella of a far more participatory model of medicine and health care.”
Nothing worked for my depression — until I tried meditation
Keri Wiginton of the Washington Post details her history of depression and how she took charge of her negative thought loops through meditation.
“Mindfulness goes to Parliament” Dr. Judson Brewer just returned from a trip to meet with the Speaker of the House of Commons (Honorable Geoff Regan, right) and other members of the Canadian Parliament (Honorable Scott Brison, President of the Treasury Board, left).
News on the topic of Digital Medicine.
Guided meditation platform Headspace announced the launch of Headspace Health, a digital medicine subsidiary aimed at delivering prescription meditation tools for physical ailments.
The new company plans to deliver the world’s first prescription meditation app in 2020 when it anticipates the introduction of the first product in its portfolio of newly developed, clinically-validated and FDA-cleared meditation programs specifically designed to treat a broad range of chronic diseases.